Blog

Posted: 29 june 2026

Thalia Therapeutics acquires US firm backed by fundraise

AIM-listed biotechnology company Thalia Therapeutics has announced the acquisition of US-based oncology firm Sanmirna Therapeutics alongside an oversubscribed £2.75m fundraise. Read more here.

Mini robot could simplify dental treatment

Researchers at the University of Basel’s Department of Biomedical Engineering have developed a small robot. The prototype is about the size of a wine cork and measures 43 by 26 by 28 millimetres. The prototype, called MIR, short for Miniature…

Blood metabolites reveal lifestyle links to brain health before dementia

In a recent study published in the journal Nature Aging, researchers investigated the relationships between blood metabolites, magnetic resonance imaging (MRI) measures, and general cognition in middle-aged adults without dementia. Read more here.

Hackensack Meridian Health and Hunterdon Health explore merger

Hunterdon Health and Hackensack Meridian Health in New Jersey have signed a letter of intent to explore a merger of the two health systems. Hackensack Meridian Health and Hunterdon Health would use their shared resources, expertise and advanced technologies to expand…

College students are turning to AI for mental health needs

Those experiencing more severe mental health symptoms consult artificial intelligence for support at higher rates than their peers, according to researchers at Mass General Brigham. They offer guidance for healthcare providers, schools and developers. Read more here.

Oura, LillyDirect team up to support GLP-1 users

The collaboration gives LillyDirect customers access to a free Oura Ring sizing kit and connects Lilly's medication-access platform with Oura's wearable-based GLP-1 support tools. Read more here.

Shaping the Future of Healthcare: Insights from Prof. Shafi Ahmed at GIANT Health

Healthcare innovation continues to evolve at an extraordinary pace — driven by advances in AI, digital health, virtual care, and new models of medical education. At the centre of many of these conversations is Prof. Shafi Ahmed, our Chairman and…

Owkin, Sanofi expand AI collaboration to build drug development AI agents

Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development. Read more here.

First AI-designed 'universal vaccine' tested in humans: UK researchers

The trial marks the first time a vaccine whose active ingredient was entirely designed by AI has been tested in humans, researchers at the University of Cambridge in the U.K. The experimental jab is intended to be a "universal vaccine"…

Alzheimer’s blood test around ages 53-69 may help detect early cognitive decline

One tool that doctors are beginning to use to help predict a person’s Alzheimer’s disease risk in its earliest stages is through blood tests that search for specific biomarkersTrusted Source in the blood. Now, a new study published in The Lancet,Trusted Source primarily funded by the…

Celebrating the GIANT Health Past Sponsors & Exhibitors Driving Healthcare Innovation

Every year, GIANT Health brings together a powerful ecosystem of organisations working across NHS transformation, digital health, life sciences, procurement, and healthcare innovation. The strength of the event lies in its partners — the sponsors and exhibitors who bring cutting-edge…

Guiding the Future of Healthcare Innovation: The GIANT Health Board of Advisors

Behind every successful ecosystem is a group of experts helping shape its direction, ensure relevance, and maintain its focus on real-world impact. At GIANT Health, this role is fulfilled by our Board of Advisors — a distinguished group of senior…

Get Involved

On the day